+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Specialty Drug Distribution Market by Distribution Channel, Therapeutic Area, Product Type, End User, Dosage Form - Global Forecast to 2030- Product Image
Specialty Drug Distribution Market by Distribution Channel, Therapeutic Area, Product Type, End User, Dosage Form - Global Forecast to 2030- Product Image
Sale

Specialty Drug Distribution Market by Distribution Channel, Therapeutic Area, Product Type, End User, Dosage Form - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4807807
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The specialty drug distribution market is rapidly evolving as advanced therapies, complex handling requirements, and new trade policies drive shifts in operational models and technology adoption. Leading companies are rethinking supply chains to manage risks and sustain growth in more patient-centric healthcare environments.

Market Snapshot: Specialty Drug Distribution Market Growth

The specialty drug distribution market grew from USD 5.47 billion in 2024 to USD 6.29 billion in 2025 and is projected to reach USD 12.26 billion by 2030 at a CAGR of 14.40%. This growth is fueled by increasing demand for therapies addressing chronic, rare, and complex diseases, with distribution frameworks advancing to meet stricter requirements and heightened expectations from manufacturers, payers, and providers. As the landscape becomes more data-driven and connected, visibility and resilience have become critical competitive differentiators for firms operating in this sector.

Scope & Segmentation of the Specialty Drug Distribution Market

  • Distribution Channels: Alternative channels (including mail order pharmacy and specialty distributors), hospital pharmacies (via direct ship and wholesaler distribution), online pharmacies (manufacturer direct and third-party platform), and retail pharmacies (chain and independent).
  • Therapeutic Areas: Autoimmune and inflammatory diseases, infectious diseases, neuroscience, oncology, rare diseases (including orphan and ultra-orphan drugs).
  • Product Types: Biologics, cell and gene therapies (including both cell therapies and gene therapies), small molecule drugs, and specialty generics.
  • End Users: Clinics, home healthcare (infusion at home, oral self-administration), hospitals, and long-term care facilities.
  • Dosage Forms: Injectables (such as prefilled syringes and vials), oral solids, and topicals.
  • Key Regions: Americas (with a focus on the US, Canada, Mexico, Brazil, Argentina, and major US states), Europe, Middle East & Africa (covering the UK, Germany, France, Russia, Italy, Spain, and additional EMEA markets), and Asia-Pacific (including China, India, Japan, Australia, South Korea, and major Southeast Asian countries).
  • Lead Companies: Cencora, McKesson, Cardinal Health, Walgreens Boots Alliance, CVS Health, Owens & Minor, Morris & Dickson, Anda, FFF Enterprises, H.D. Smith.
  • Key Technologies: Digital platforms for order fulfillment, blockchain for authentication, temperature tracking systems, predictive analytics for inventory management, and enhanced supply chain automation.

Key Takeaways for Senior Decision-Makers

  • Market participants are shifting toward integrated, patient-focused distribution models that leverage direct-to-patient, mail order, and digital pharmacy services alongside established channels.
  • Technology solutions such as blockchain and real-time tracking enable improved efficiency, compliance, and risk mitigation at every point in the supply chain.
  • Strategic partnerships and mergers are consolidating the specialty distribution sector, enabling broader geographic reach and stronger value-based care integration.
  • Diversified sourcing and inventory planning are essential for mitigating supply disruptions and responding effectively to regulatory or market changes.
  • Regional trends highlight unique market access requirements in the Americas, EMEA, and Asia-Pacific, emphasizing the need for localized adaptation of distribution strategies and regulatory compliance.

Tariff Impact: Navigating 2025 Policy Changes

Forthcoming U.S. tariff adjustments in 2025 will increase duties on specialty drugs, impacting biologics and select small molecules. These levies will intensify cost pressures across distribution channels, driving manufacturers, distributors, and specialty pharmacies to assess supply agreements, shift sourcing strategies, and fortify inventory management processes. Forward-thinking stakeholders are establishing multi-year contracts and investing in data-enabled logistics to reduce volatility and ensure continuous access to critical therapies.

Methodology & Data Sources

This analysis draws on a multi-stage research approach, combining a comprehensive review of industry publications, regulatory filings, and proprietary market databases. Primary research included interviews with executives from specialty distributors, manufacturers, providers, and payers to validate trends and gather frontline insights. Analytical rigor was maintained through data triangulation, expert panel review, and cross-validation with public and private datasets to ensure robust, actionable conclusions.

Why This Report Matters

  • Enables data-driven supply chain decisions and strategic adaptations to policy shifts and market innovation.
  • Supports executive planning for channel optimization, regional investments, and technology upgrades.
  • Strengthens risk management and gives a clear view of competitive dynamics in a rapidly transforming, high-value market.

Conclusion

Specialty drug distribution is advancing amid regulatory developments and accelerating innovation. Senior leaders can leverage layered market insights to optimize networks, strengthen resilience, and realize growth in a competitive, patient-centric market environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Specialty Drug Distribution Market, by Distribution Channel
8.1. Introduction
8.2. Alternative Channel
8.2.1. Mail Order Pharmacy
8.2.2. Specialty Distributor
8.3. Hospital Pharmacy
8.3.1. Direct Ship
8.3.2. Wholesaler Distribution
8.4. Online Pharmacy
8.4.1. Manufacturer Direct
8.4.2. Third Party Platform
8.5. Retail Pharmacy
8.5.1. Chain Pharmacy
8.5.2. Independent Pharmacy
9. Specialty Drug Distribution Market, by Therapeutic Area
9.1. Introduction
9.2. Autoimmune & Inflammatory Diseases
9.3. Infectious Diseases
9.4. Neuroscience
9.5. Oncology
9.6. Rare Diseases
9.6.1. Orphan Drugs
9.6.2. Ultra-Orphan Drugs
10. Specialty Drug Distribution Market, by Product Type
10.1. Introduction
10.2. Biologics
10.3. Cell And Gene Therapies
10.3.1. Cell Therapies
10.3.2. Gene Therapies
10.4. Small Molecule Drugs
10.5. Specialty Generics
11. Specialty Drug Distribution Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Healthcare
11.3.1. Infusion At Home
11.3.2. Oral Self Administration
11.4. Hospitals
11.5. Long Term Care Facilities
12. Specialty Drug Distribution Market, by Dosage Form
12.1. Introduction
12.2. Injectables
12.2.1. Pre Filled Syringes
12.2.2. Vials
12.3. Oral Solids
12.4. Topicals
13. Americas Specialty Drug Distribution Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Specialty Drug Distribution Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Specialty Drug Distribution Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Cencora, Inc.
16.3.2. McKesson Corporation
16.3.3. Cardinal Health, Inc.
16.3.4. Walgreens Boots Alliance, Inc.
16.3.5. CVS Health Corporation
16.3.6. Owens & Minor, Inc.
16.3.7. Morris & Dickson Co., L.L.C.
16.3.8. Anda, Inc.
16.3.9. FFF Enterprises, Inc.
16.3.10. H. D. Smith, LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SPECIALTY DRUG DISTRIBUTION MARKET MULTI-CURRENCY
FIGURE 2. SPECIALTY DRUG DISTRIBUTION MARKET MULTI-LANGUAGE
FIGURE 3. SPECIALTY DRUG DISTRIBUTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SPECIALTY DRUG DISTRIBUTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL ORDER PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DIRECT SHIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY WHOLESALER DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AUTOIMMUNE & INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ORPHAN DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ULTRA-ORPHAN DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY GENERICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INFUSION AT HOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ORAL SELF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LONG TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ORAL SOLIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TOPICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 86. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 87. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 88. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 89. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 90. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 92. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 94. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 95. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 96. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 99. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 100. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 105. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 162. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 165. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 166. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 167. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 168. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 169. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 171. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 173. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 174. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 175. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 178. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 179. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 180. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 181. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 182. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 184. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 186. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 201. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 204. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 205. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 206. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 207. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 208. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 210. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 212. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 213. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 214. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 217. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 218. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 219. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 220. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 221. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 223. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 225. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 226. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 266. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 269. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 270. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 271. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 272. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 273. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 275. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 277. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 278. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 292. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 295. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 296. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 297. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 298. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RARE DISEASES, 2018-2030 (USD MILLION)
TABLE 299. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 301. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 303. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 304. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 305. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ALTERNATIVE CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Specialty Drug Distribution market report include:
  • Cencora, Inc.
  • McKesson Corporation
  • Cardinal Health, Inc.
  • Walgreens Boots Alliance, Inc.
  • CVS Health Corporation
  • Owens & Minor, Inc.
  • Morris & Dickson Co., L.L.C.
  • Anda, Inc.
  • FFF Enterprises, Inc.
  • H. D. Smith, LLC

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.26 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Specialty Pharmaceuticals Market by Therapeutic Area, Product Type, Route of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Specialty Pharmaceuticals Market by Therapeutic Area, Product Type, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Targeted Drugs for Parkinson's Disease Market by Therapy Type, Distribution Channel, Route Of Administration, Disease Stage, End User, Patient Age Group, Price Range - Global Forecast to 2030 - Product Image

Targeted Drugs for Parkinson's Disease Market by Therapy Type, Distribution Channel, Route Of Administration, Disease Stage, End User, Patient Age Group, Price Range - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Dopamine Agonist Market Size, Share & Trends Analysis Report by Drug (Non-Ergot Dopamine Agonists, Ergot Alkaloids), Route of Administration (Oral, Injectable), Application, Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Dopamine Agonist Market Size, Share & Trends Analysis Report by Drug (Non-Ergot Dopamine Agonists, Ergot Alkaloids), Route of Administration (Oral, Injectable), Application, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 153 Pages
  • Global
From
U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • United States
From
Specialty Pharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Specialty Pharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From

About the Specialty Drug Distribution Market

The Specialty Drug Distribution market is a segment of the pharmaceutical industry that focuses on the distribution of specialty drugs. These drugs are typically high-cost, complex medications that require special handling and storage. Specialty drugs are often used to treat chronic and rare conditions, such as cancer, multiple sclerosis, and HIV/AIDS. Specialty drug distributors are responsible for ensuring that these drugs are delivered to the appropriate healthcare providers in a timely and safe manner. They also provide support services, such as patient education and reimbursement assistance. The Specialty Drug Distribution market is highly regulated, with stringent requirements for drug storage, handling, and distribution. This ensures that the drugs are delivered safely and securely to the appropriate healthcare providers. Some companies in the Specialty Drug Distribution market include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc., and Express Scripts Holding Company. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.